Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: AMG 139
RN: 1801551-39-2


  • Targets interleukin-23; for treatment of Crohn's disease; in phase II clinical trials (2015).

    Amgen: AMG 139 is a human monoclonal antibody that neutralises IL-23 interaction with its receptor while sparing IL-12. It is being investigated as a treatment for a variety of inflammatory disorders. AMG 139 is being investigated in Phase 1 for Crohns disease, with lifecycle possibilities in psoriasis and other inflammatory conditions. (Manufacturer)

Molecular Formula

  • Unspecified
* denotes mobile formatted website

Links to Resources

Names and Synonyms

  • AMG 139

Registry Numbers

CAS Registry Number

  • 1801551-39-2

System Generated Number

  • 1801551392